📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Immune dysregulation increases the incidence of delayed-type drug hypersensitivity reactions. (2020)

First Author: Naisbitt DJ

Attributed to: MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/all.14127

PubMed Identifier: 31758810

Publication URI: http://europepmc.org/abstract/MED/31758810

Type: Journal Article/Review

Volume: 75

Parent Publication: Allergy

Issue: 4

ISSN: 0105-4538